Expert sees more diagnostic, therapeutic use for nanoparticle imaging

12/2/2008 | HealthImaging.com

Recent research advances have enabled scientists to bind nanoparticles to radionuclides for MR, SPECT, PET and near-infrared optical imaging to detect inflammation or certain ailments, said Michael J. Welch, a nuclear medicine expert. He said nanoparticles will help bring a new era of diagnostic imaging and personalized medicine. The initial clinical use of nanoparticle-based agents will be for cardiac problems, Welch predicted.

View Full Article in:

HealthImaging.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Actuary
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
MetLife
Bridgewater, NJ